Skip to main content
SpringerLink
Log in

On the safety of Bacillus subtilis and B. amyloliquefaciens: a review

  • Mini-review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • AMFEP (Association of Microbial Food Enzyme Producers) (1990) Regulatory aspects of food enzymes produced by recombinant microorgganisms. Association of Microbial Food Enzyme Producers, Bruxelles

    Google Scholar 

  • Andersen JR, Diderichsen BK, Hjortkjaer RK, Boer AS de, Bootman J, West H, Ashby R (1987) Determining the safety of maltogenic amylase produced by rDNA technology. J Food Protect 50:521–526

    Google Scholar 

  • Bielecki J, Youngmans P, Connelly P, Portnoy DA (1990) Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 345:175–176

    Google Scholar 

  • Burkholder PR, Giles NH (1947) Induced biochemical mutants in Bacillus subtilis. Am J Bot 34:345–348

    Google Scholar 

  • Cotton DJ, Gill VJ, Marshall DJ, Gress J, Thaler M, Pizzo PA (1987) Clinical features and therapeutic interventions in 17 cases of Bacillus bacteriemia in an immunosuppressed patient population. J Clin Microbiol 25:672–674

    Google Scholar 

  • CPC International (1986) GRAS Petition 4G0293 proposing that alpha-amylase from a strain of Bacillus subtilis (ATCC 39 705) containing the gene for alpha-amylase from B. stearothermophilus inserted by recombinant DNA techniques be affirmed as GRAS as a direct human food ingredient. Notice of Filing. Federal Register 51:10571

    Google Scholar 

  • Diderichsen B et al. (1990) The conditions for contained use of genetically engineered microorganisms and cells for industrial production in Europe. Biotechnol Forum Eur 7:484–485

    Google Scholar 

  • Djien KS, Hesseltine CW (1979) Tempe and related foods. In: Rose AH (ed) Economic microbiology, vol 4. Academic Press, London, pp 116–140

    Google Scholar 

  • Donzis PB, mondino BJ, Wiessman BA (1988) Bacillus keratitis associated with contaminated contact lens care systems. Am J Ophthalmol 105:195–197

    Google Scholar 

  • Doyle RJ, Keller KF, Ezzell JW (1985) In: Ballows A, Hausler WJ, Shadomy HJ (eds) Manual of clinical microbiology, 4th edn. American Society for Microbiology, Washington, D. C., pp 211–215

    Google Scholar 

  • Ehrlich SD (1977) Replication and expression of plasmids from Staphylococcus aureus in Bacillus subtilis. Proc Natl Acad Sci USA 74:1680–1682

    Google Scholar 

  • Enzyme Bio-Systems (1988) GRAS Petition 7G0328 proposing that alpha-amylase from a strain of Bacillus subtilis containing a Bacillus megaterium alpha-amylase gene be affirmed as GRAS as a direct human food ingredient. Notice of Filing. Federal Register 53:16191

    Google Scholar 

  • Finch JE, Prince J, Hawksworth M (1978) A bacteriological survey of the domestic environment. J Appl Bacteriol 45:364–375

    Google Scholar 

  • Gordon RE, Haynes WC, Pang CH-N (1973) The genus Bacillus. In: Gordon RE, Haynes WC, Pang CH-N (eds) Agricultural Handbook no. 427. US Department of Agriculture, Washington, D. C., pp 23–25

    Google Scholar 

  • IFBC (International Food Biotechnology Council) (1990) Biotechnologies and food: assuring the safety of foods produced by genetic modification. Regul Toxicol Pharmacol 12:Special Issue

  • Ihde DC, Armstrong D (1973) Clinical spectrum of infection due to Bacillus species. Am J Med 55:839–845

    Google Scholar 

  • Jonas M, Cunha BA, Greensher J (1981) Bacillus subtilis osteomycelitis. South Med J 74:1421–1422

    Google Scholar 

  • Kiss T, Gratwohl A, Frei R, Osterwalder B, Tichelli A, Speck B (1988) Bacillus subtilis Infectionen. Schweiz Rundsch Med 77:1219–1223

    Google Scholar 

  • Kramer JM, Gilbert RJ (1989) Bacillus cereus and other Bacillus species. In: Doyle MP (ed) Foodborne bacterial pathogens. Dekker, New York, pp 21–70

    Google Scholar 

  • Logan NA (1988) Bacillus species of medical and veterinary importance. J Med Microbiol 25:157–165

    Google Scholar 

  • National Academy of Sciences (1987) Introduction of recombinant DNA-engineered organisms into the environment: key issues. National Academy Press, Washington, DC

    Google Scholar 

  • Novo Laboratories (1990) GRAS Petition 7G0326 proposing that maltogenic amylase enzyme preparation derived from a genetically modified Bacillus subtilis be affirmed as GRAS as a direct human food ingredient. Federal Register 55:9772–9773

    Google Scholar 

  • OECD (1986) Recombinant DNA safety considerations. Paris

  • Pariza MW, Foster EM (1983) Determining the safety of enzymes used in food processing. J Food Prot 46:453–468

    Google Scholar 

  • Pennington JE, Gibbons ND, Strobeck JE, Simpson GL, Myerowitz RL (1976) Bacillus species infections in patients with haematologic infections. J Am Med Assoc 235:1473–1474

    Google Scholar 

  • Priest FG (1990) Products and applications. In: Harwood CR (ed) Bacillus. Plenum, New York, pp 293–320

    Google Scholar 

  • Priest FG, Goodfellow M, Shute LA, Berkeley RCW (1987) Bacillus amyloliquefaciens sp. nov., nom. rev. Int J Syst Bacteriol 37:69–71

    Google Scholar 

  • Reller LB (1973) Endocarditis caused by Bacillus subtilis. Am J Clin Pathol 60:714–718

    Google Scholar 

  • Richard D, Auwera P van der, Snoeck R, Daneau D, Meunier F (1988) Nosocomial bacteremia caused by Bacillus species. Clin Microbiol Infect Dis 7:783–785

    Google Scholar 

  • Shamsuddin D, Tuason CU, Levy C, Curtin J (1982) Bacillus cereus phanophthalmitis: source of the organism. Rev Infect Dis 4:97–103

    Google Scholar 

  • Tuazon CV, Murray HW, Levy C, Solny MN, Curtin JA, Sheagrren JN (1979) Serious infections from Bacillus sp. J Am Med Assoc 241:1137–1140

    Google Scholar 

  • Welker NE, Campbell LL (1967) Unrelatedness of Bacillus amyloliquefaciens and Bacillus subtilis. J Bacteriol 94:1124–1130

    Google Scholar 

  • Weller PF, Nicholson A (1979) The spectrum of Bacillus bacteremias in heroin addicts. Arch Internal Med 139:293–294

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Novo Nordisk A/S, Novo Allé, DK-2880, Bagsvaerd, Denmark

    Anne de Boer Sietske & Børge Diderichsen

Authors
  1. Anne de Boer Sietske
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Børge Diderichsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Offsprint requests to: B. Diderichsen

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Boer Sietske, A., Diderichsen, B. On the safety of Bacillus subtilis and B. amyloliquefaciens: a review. Appl Microbiol Biotechnol 36, 1–4 (1991). https://doi.org/10.1007/BF00164689

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00164689

Keywords

Search

Navigation